AIM: To investigate the correlations between self-reported symptoms of irritable bowel syndrome (IBS) and the gastrointestinal (GI) microbiota composition. METHODS: Fecal samples were collected from a total of 44 subjects diagnosed with IBS. Their symptoms were monitored with a validated inflammatory bowel disease questionnaire adjusted for IBS patients. Thirteen quantitative real-time polymerase chain reaction assays were applied to evaluate the GI microbiota composition. Eubacteria and GI bacterial genera (Bifidobacterium, Lactobacillus and Veillonella), groups (Clostridium coccoides/Eubacterium rectale, Desulfovibrio desulfuricans) and distinct bacterial phylotypes [closest 16S rDNA sequence resemblance to species Bifidobacterium catenulatum, Clostridium cocleatum, Collinsella aerofaciens (C. aerofaciens), Coprococcus eutactus (C. eutactus), Ruminococcus torques and Streptococcus bovis] with a suspected association with IBS were quantified. Correlations between quantities or presence/absence data of selected bacterial groups or phylotypes and various IBS-related symptoms were investigated. RESULTS: Associations were observed between subjects' self-reported symptoms and the presence or quantities of certain GI bacteria. A Ruminococcus torques (R. torques)-like (94% similarity in 16S rRNA gene sequence) phylotype was associated with severity of bowel symptoms. Furthermore, among IBS subjects with R. torques 94% detected, the amounts of C. cocleatum 88%, C. aerofaciens-like and C. eutactus 97% phylotypes were significantly reduced. Interesting observations were also made concerning the effect of a subject's weight on GI microbiota with regard to C. aerofaciens-like phylotype, Bifidobacterium spp. and Lactobacillus spp. CONCLUSION: Bacteria seemingly affecting the symptom scores are unlikely to be the underlying cause or cure of IBS, but they may serve as biomarkers of the condition.
AIM: To investigate the correlations between self-reported symptoms of irritable bowel syndrome (IBS) and the gastrointestinal (GI) microbiota composition. METHODS: Fecal samples were collected from a total of 44 subjects diagnosed with IBS. Their symptoms were monitored with a validated inflammatory bowel disease questionnaire adjusted for IBSpatients. Thirteen quantitative real-time polymerase chain reaction assays were applied to evaluate the GI microbiota composition. Eubacteria and GI bacterial genera (Bifidobacterium, Lactobacillus and Veillonella), groups (Clostridium coccoides/Eubacterium rectale, Desulfovibrio desulfuricans) and distinct bacterial phylotypes [closest 16S rDNA sequence resemblance to species Bifidobacterium catenulatum, Clostridium cocleatum, Collinsella aerofaciens (C. aerofaciens), Coprococcus eutactus (C. eutactus), Ruminococcus torques and Streptococcus bovis] with a suspected association with IBS were quantified. Correlations between quantities or presence/absence data of selected bacterial groups or phylotypes and various IBS-related symptoms were investigated. RESULTS: Associations were observed between subjects' self-reported symptoms and the presence or quantities of certain GI bacteria. A Ruminococcus torques (R. torques)-like (94% similarity in 16S rRNA gene sequence) phylotype was associated with severity of bowel symptoms. Furthermore, among IBS subjects with R. torques 94% detected, the amounts of C. cocleatum 88%, C. aerofaciens-like and C. eutactus 97% phylotypes were significantly reduced. Interesting observations were also made concerning the effect of a subject's weight on GI microbiota with regard to C. aerofaciens-like phylotype, Bifidobacterium spp. and Lactobacillus spp. CONCLUSION: Bacteria seemingly affecting the symptom scores are unlikely to be the underlying cause or cure of IBS, but they may serve as biomarkers of the condition.
Authors: Vinton S Chadwick; Wangxue Chen; Dairu Shu; Barbara Paulus; Peter Bethwaite; Andy Tie; Ian Wilson Journal: Gastroenterology Date: 2002-06 Impact factor: 22.682
Authors: E Carol McWilliam Leitch; Alan W Walker; Sylvia H Duncan; Grietje Holtrop; Harry J Flint Journal: Environ Microbiol Date: 2007-03 Impact factor: 5.491
Authors: Hans G H J Heilig; Erwin G Zoetendal; Elaine E Vaughan; Philippe Marteau; Antoon D L Akkermans; Willem M de Vos Journal: Appl Environ Microbiol Date: 2002-01 Impact factor: 4.792
Authors: Jeroen Aerssens; Michael Camilleri; Willem Talloen; Leen Thielemans; Hinrich W H Göhlmann; Ilse Van Den Wyngaert; Theo Thielemans; Ronald De Hoogt; Christopher N Andrews; Adil E Bharucha; Paula J Carlson; Irene Busciglio; Duane D Burton; Thomas Smyrk; Raul Urrutia; Bernard Coulie Journal: Clin Gastroenterol Hepatol Date: 2008-02 Impact factor: 11.382
Authors: Zhao Xiang Bian; Zhi Li; Zhi Xin Huang; Man Zhang; Hong Li Chen; Hong Xi Xu; Joseph J Y Sung Journal: J Gastroenterol Date: 2009-05-09 Impact factor: 7.527
Authors: Delphine M Saulnier; Kevin Riehle; Toni-Ann Mistretta; Maria-Alejandra Diaz; Debasmita Mandal; Sabeen Raza; Erica M Weidler; Xiang Qin; Cristian Coarfa; Aleksandar Milosavljevic; Joseph F Petrosino; Sarah Highlander; Richard Gibbs; Susan V Lynch; Robert J Shulman; James Versalovic Journal: Gastroenterology Date: 2011-07-08 Impact factor: 22.682